​

Caris Life Sciences Ownership | Who Owns Caris Life Sciences?


OverviewForecastRevenueFinancialsChartTranscripts

Caris Life Sciences Ownership Summary


Caris Life Sciences is owned by 51.83% institutional investors, 48.52% insiders. Fmr is the largest institutional shareholder, holding 13.55% of CAI shares. Fidelity Contrafund is the top mutual fund, with 1.52% of its assets in Caris Life Sciences shares.

CAI Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCaris Life Sciences51.83%48.52%-0.35%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr38.33M13.55%$1.17B
Braidwell lp8.26M2.92%$147.12M
Blackrock funding, inc. /de7.86M2.78%$240.90M
Pointstate capital lp6.83M2.42%$121.69M
Vanguard capital management5.73M2.03%$175.63M
T. rowe price investment management5.08M1.80%$90.51M
Vanguard portfolio management4.73M1.67%$144.88M
Capital world investors4.39M1.55%$134.45M
Bnp paribas arbitrage, snc3.51M1.24%$107.57M
Jpmorgan chase3.44M1.22%$108.67M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
J. h. whitney equity partners vi1.75M100.00%$53.62M
Sixth street partners management company3.03M19.16%$92.89M
Braidwell lp8.26M5.44%$147.12M
Mak capital one1.94M4.84%$34.52M
Pointstate capital lp6.83M1.56%$121.69M
Point72 (difc)654.79K1.30%$19.81M
Pura vida investments25.50K1.23%$454.41K
Pembroke management299.79K1.14%$9.18M
First light asset management403.92K1.12%$11.88M
Champlain investment partners1.05M1.11%$32.28M

Top Buyers

HolderShares% AssetsChange
Fmr38.33M0.05%7.41M
Capital world investors4.39M0.02%3.18M
Blackrock funding, inc. /de7.86M0.00%2.33M
Mak capital one1.94M4.84%1.94M
Vanguard capital management5.73M0.00%1.45M

Top Sellers

HolderShares% AssetsChange
Coatue management---9.82M
J. h. whitney equity partners vi1.75M100.00%-9.51M
Silver lake group---5.29M
Sixth street partners management company3.03M19.16%-4.29M
Price t rowe associates inc /md/1.21M0.00%-3.17M

New Positions

HolderShares% AssetsChangeValue
Mak capital one1.94M4.84%1.94M$34.52M
Ing groep nv496.10K0.09%496.10K$15.20M
Ieq capital363.49K0.05%363.49K$11.13M
Pembroke management299.79K1.14%299.79K$9.18M
Dekabank deutsche girozentrale292.21K0.01%292.21K$9.22M

Sold Out

HolderChange
Tortoise investment management-1.00
Mv capital management-2.00
Wealth preservation advisors-3.00
Massmutual trust co fsb/adv-25.00
Parallel advisors-34.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202625422.12%146,450,281-6.55%5158.99%17519.05%4727.03%
Mar 31, 202677-60.31%15,582,500-89.27%-0.04%63-54.01%7-78.79%
Dec 31, 2025101-30.82%24,811,123-78.12%80.54%78-22.77%12-40.00%
Sep 30, 202546-61.02%8,557,378-92.17%130.05%38-67.80%5-
Jun 30, 2025117-106,907,974-616-117---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Contrafund4.37M1.52%297.08K
Vanguard MStar Total Stk Mkt Idx Invest4.07M1.44%12.68K
Vanguard Total Stock Mkt Idx Inv4.05M1.43%878.95K
Vanguard Morn Total Stk Mkt Idx Investor4.05M1.43%878.95K
JPM US Mid Cap Growth-Composite3.32M1.17%1.63M
American Funds SMALLCAP World A3.01M1.06%1.83M
Vanguard Small Cap Index2.86M1.01%-61.63K
T. Rowe Price US Mid-Cap Growth Equity2.70M0.96%-1.82K
T. Rowe Price Mid-Cap Growth2.70M0.96%-651.00
JPMorgan Mid Cap Growth I2.09M0.73%-33.25K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 22, 2026Denton John Russel See RemarksSell$238.63K
Sep 17, 2026Brille Brian J See RemarksSell$12.13M
Sep 03, 2026Spetzler David Baxley PresidentSell$9.73M
Sep 04, 2026Spetzler David Baxley PresidentSell$2.95M
Sep 03, 2026Spetzler David Baxley PresidentSell$2.15M

Insider Transactions Trends


DateBuySell
2026 Q3-5
2026 Q22-
2026 Q1--
2025 Q422
2021 Q4--

CAI Ownership FAQ


Who Owns Caris Life Sciences?

Caris Life Sciences shareholders are primarily institutional investors at 51.83%, followed by 48.52% insiders and -0.35% retail investors. The average institutional ownership in Caris Life Sciences's industry, Biotech Stocks , is 385.89%, which Caris Life Sciences falls below.

Who owns the most shares of Caris Life Sciences?

Caris Life Sciences’s largest shareholders are Fmr (38.33M shares, 13.55%), Braidwell lp (8.26M shares, 2.92%), and Blackrock funding, inc. /de (7.86M shares, 2.78%). Together, they hold 19.25% of Caris Life Sciences’s total shares outstanding.

Does Blackrock own Caris Life Sciences?

BlackRock is not among the top 10 institutional shareholders of Caris Life Sciences.

Who is Caris Life Sciences’s biggest shareholder by percentage of total assets invested?

J. h. whitney equity partners vi is Caris Life Sciences’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 1.75M Caris Life Sciences shares, valued at 53.62M$.

Who is the top mutual fund holder of Caris Life Sciences shares?

Fidelity Contrafund is the top mutual fund holder of Caris Life Sciences shares, with 1.52% of its total shares outstanding invested in 4.37M Caris Life Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools